Corcept Therapeutics Incorporated

US$72.77As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CORTHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 26.43%
Div yield —
ROE 22.15%
Biotechnology
Beta (5Y) 0.56
PE TTM 54.74
TSR TTM (0.95%)
Mkt cap US$7.964B
ROIC 25.24%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$75
3.03%
66.69%
Sell 10|3|1|4|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.99
0.97
1.02
1.02
19.82%
20.26%
25.84%
13.93%
Revenue$M
356.2
368.8
388.5
381.6
4.90%
2.66%
9.51%
10.70%
Peers (US$7.964B)
Cap (US$)
PE
8.031B
39.82x
Capital
TTM
5Y
10Y
Leveragex
0.320
0.085
0.073
EBIT/Intx
0.294
0.452
0.391
Own earn%
(8.69)
81.95
55.78
Sh yield%
35.31
29.29
27.23
Owners
Insiders/Inst%
9.74
54.44
Short interest%
2.00
SBC / revenue%
4.57
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
2–5
$1 testx
—
Incr. ROIC%
1